The Paid up capital of the Company is less than Rs. 10/-(Ten) Crores and Net Worth of the Company is less than Rs. 25 /- (Twenty-Five)Crores as on 31.03.2025, so there is non-applicability ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rekvina Laboratories Ltd has informed BSE that it is exempt from filing consolidated related party transaction disclosures under SEBI LODR Regulation 23(9) for the half year ended 30 September 2025. The exemption applies because the company's paid-up equity share capital is below Rs. 10 crore and its net worth is below Rs. 25 crore as on 31 March 2025, making it fall under Regulation 15(2) of the SEBI Listing Regulations. Several corporate governance provisions, including related party transaction reporting, do not apply to companies below these size thresholds.
This is a routine compliance filing confirming exemption from a disclosure requirement, not an operational or financial event. No direct impact on shareholders or stock price, though it signals that the company remains small-cap with limited capital base and net worth.